BioNTech
-
Penn and BioNTech Partner on New $50M Fund for Early-Stage Life Sciences Companies
The University of Pennsylvania and global biopharmaceutical company BioNTech have launched a $50 million fund to support early-stage life science companies emerging from the university,…
-
BioNTech Agrees to Pay $467M to Penn as Part of COVID-19 Vaccine Royalties Settlement
University of Pennsylvania will receive $467 million from BioNTech as part of a settlement in a lawsuit over COVID-19 vaccine royalties, writes John George for…
-
Abington’s Katalin Karikó Inducted Into 2024 Class of Distinguished Daughters of Pennsylvania
Katalin Karikó, a Nobel Prize laureate, Penn professor, and renowned mRNA researcher from Abington, has been inducted into the 2024 Class of Distinguished Daughters of…
-
University of Pennsylvania Suing German Drugmaker BioNTech Over COVID-19 Vaccine Payments
The University of Pennsylvania submitted a federal civil lawsuit against BioNTech, alleging that the German drugmaker did not pay Penn its full share of royalties…
-
Penn Medicine’s Katalin Karikó’s New Book Shares Her Journey from Rejection to COVID-19 Vaccine Hero
Abington biochemist Katalin Karikó recently published a new book, Breaking Through: My Life in Science, which provides a vivid account of her life and decades…
-
Penn Likely to Be Top Research Institution for Licensing Revenue, Thanks to Abington Resident
The University of Pennsylvania is likely to once again be on the top among U.S. research institutions for licensing revenue, thanks to COVID-19 vaccines lead…
Founding Partners
Advertisement
Affiliate Partners
